Comparison of cardiovascular outcomes between SGLT2 inhibitors in diabetes mellitus

Comparison of cardiovascular outcomes between SGLT2 inhibitors in diabetes mellitus

Abstract Background There have been scarce data comparing cardiovascular outcomes between individual sodium-glucose cotransporter-2 (SGLT2) inhibitors. We aimed to compare the subsequent cardiovascular risk between individual SGLT2 inhibitors. Methods We analyzed 25,315 patients with diabetes mellit...

Full description

Bibliographic Details
Main Authors: Yuta Suzuki, Hidehiro Kaneko, Akira Okada, Hidetaka Itoh, Satoshi Matsuoka, Katsuhito Fujiu, Nobuaki Michihata, Taisuke Jo, Norifumi Takeda, Hiroyuki Morita, Kentaro Kamiya, Atsuhiko Matsunaga, Junya Ako, Koichi Node, Hideo Yasunaga, Issei Komuro
Format: Article
Language:English
Published: BMC 2022-05-01
Series:Cardiovascular Diabetology
Subjects:
SGLT2 inhibitor
Cardiovascular disease
Diabetes mellitus
Online Access:https://doi.org/10.1186/s12933-022-01508-6

Internet

https://doi.org/10.1186/s12933-022-01508-6

Similar Items